WallStreetZenWallStreetZen

NASDAQ: MYNZ
Mainz Biomed Nv Stock Forecast, Predictions & Price Target

Open Broker Account

Analyst price target for MYNZ

Based on 1 analyst offering 12 month price targets for Mainz Biomed Nv.
Min Forecast
$25.00+262.32%
Avg Forecast
$25.00+262.32%
Max Forecast
$25.00+262.32%

Should I buy or sell MYNZ stock?

Based on 1 analyst offering ratings for Mainz Biomed Nv.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their MYNZ stock forecasts and price targets.

MYNZ stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
HC Wainwright & Co.
Top 5%
96
BuyInitiates Coverage On$25.00+262.32%2022-06-21

1 of 1

Forecast return on equity

Is MYNZ forecast to generate an efficient return?
Company
-99.92%
Industry
467.97%
Market
98.76%
MYNZ's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is MYNZ forecast to generate an efficient return on assets?
Company
-86.01%
Industry
9.83%
MYNZ is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

MYNZ earnings per share forecast

What is MYNZ's earnings per share in the next 2 years based on estimates from 1 analyst?
Avg 1 year Forecast
-$1.76
Avg 2 year Forecast
-$1.64

MYNZ revenue forecast

What is MYNZ's revenue in the next 2 years based on estimates from 1 analyst?
Avg 1 year Forecast
$710.0k+77.57%
Avg 2 year Forecast
$5.6M+1,288.05%
MYNZ's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

MYNZ revenue growth forecast

How is MYNZ forecast to perform vs Diagnostics & Research companies and vs the US market?
Company
77.57%
Industry
-0.3%
Market
12.8%
MYNZ's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
MYNZ's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

MYNZ vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
MYNZ$6.90$25.00+262.32%Buy
CODX$3.02$7.00+131.79%Buy
LAB$1.23$10.00+713.01%Strong Buy
MDXH$6.65$16.50+148.12%Strong Buy
ENZ$2.15N/AN/A

Mainz Biomed Nv Stock Forecast FAQ

Is Mainz Biomed Nv Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: MYNZ) stock is to Buy MYNZ stock.

Out of 1 analyst, 0 (0%) are recommending MYNZ as a Strong Buy, 1 (100%) are recommending MYNZ as a Buy, 0 (0%) are recommending MYNZ as a Hold, 0 (0%) are recommending MYNZ as a Sell, and 0 (0%) are recommending MYNZ as a Strong Sell.

If you're new to stock investing, here's how to buy Mainz Biomed Nv stock.

What is MYNZ's earnings growth forecast for 2022-2023?

(NASDAQ: MYNZ) Mainz Biomed Nv's forecast annual earnings growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of 25.4%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 46.52%.

Mainz Biomed Nv's earnings in 2022 is -$24,030,824.On average, 1 Wall Street analyst forecast MYNZ's earnings for 2022 to be -$25,490,034, with the lowest MYNZ earnings forecast at -$25,490,034, and the highest MYNZ earnings forecast at -$25,490,034.

In 2023, MYNZ is forecast to generate -$23,752,077 in earnings, with the lowest earnings forecast at -$23,752,077 and the highest earnings forecast at -$23,752,077.

What is MYNZ's revenue growth forecast for 2022-2023?

(NASDAQ: MYNZ) Mainz Biomed Nv's forecast annual revenue growth rate of 77.57% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of -0.3%, and and it is also forecast to beat the US market's average forecast revenue growth rate of 12.8%.

Mainz Biomed Nv's revenue in 2022 is $399,842.On average, 1 Wall Street analysts forecast MYNZ's revenue for 2022 to be $10,282,912, with the lowest MYNZ revenue forecast at $10,282,912, and the highest MYNZ revenue forecast at $10,282,912.

In 2023, MYNZ is forecast to generate $80,380,506 in revenue, with the lowest revenue forecast at $80,380,506 and the highest revenue forecast at $80,380,506.

What is MYNZ's forecast return on assets (ROA) for 2022-2023?

(NASDAQ: MYNZ) forecast ROA is -86.01%, which is lower than the forecast US Diagnostics & Research industry average of 9.83%.

What is MYNZ's Price Target?

According to 1 Wall Street analyst that have issued a 1 year MYNZ price target, the average MYNZ price target is $25.00, with the highest MYNZ stock price forecast at $25.00 and the lowest MYNZ stock price forecast at $25.00.

The Wall Street analyst predicted that Mainz Biomed Nv's share price could reach $25.00 by Jun 21, 2023. The average Mainz Biomed Nv stock price prediction forecasts a potential upside of 262.32% from the current MYNZ share price of $6.90.

What is MYNZ's Earnings Per Share (EPS) forecast for 2022-2023?

(NASDAQ: MYNZ) Mainz Biomed Nv's current Earnings Per Share (EPS) is -$0.02. On average, analysts forecast that MYNZ's EPS will be -$1.76 for 2022, with the lowest EPS forecast at -$1.76, and the highest EPS forecast at -$1.76. In 2023, MYNZ's EPS is forecast to hit -$1.64 (min: -$1.64, max: -$1.64).

What is MYNZ's forecast return on equity (ROE) for 2022-2023?

(NASDAQ: MYNZ) forecast ROE is -99.92%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.